Develop your idea, concept or innovation
Whenever you are excited about an idea, an innovation or (the possibility of) an invention, the first step to take is talk to one of the IXA business developers. Even if your idea is still premature and very much ‘under construction’. The sooner you let us know, the better – in particular when protection of intellectual property is at stake. We can inform you about the do’s and don’ts with respect to making your research data and results public.
We have specialized business developers for each research field. From engineering, maths and life sciences to the arts, humanities and social sciences*. They will support you in assessing the opportunities and potential pitfalls of your idea and advise you on the steps to be taken. Questions you can expect from our team are:
- Is practical application possible? Are there interested external parties?
- What problem is addressed and what solution do you offer?
- Are similar products or services already available? If so, what makes this idea, invention or innovation stand out?
- What could be potential revenues, commercial and/or societal?
The best approach to further advance your idea depends largely on the idea itself and its stage of development. IXA assist in various steps:
- search for partners for further development;
- participate in negotiations for research collaborations or licensing agreements; and
- help to set up contracts dealing with research and development, intellectual property rights, confidentiality, exchanging materials;
- assist in securing funding.
In due time, we can assist in matchmaking with companies and investors with expertise, resources, and effective business networks. In addition, IXA can assist you with legal and financial matters throughout the entire collaboration process.
Lets us help you to develop your idea and bring it to fruition.
* IXA has compiled valorisation guides especially tuned to researchers in social sciences and humanities (SSH) and life sciences (medical technology). Read more here.
Industry Alliance Office triggers Rodin Therapeutics to launch Clinical Trials in the Netherlands
Rodin Therapeutics and Amsterdam Neuroscience of Amsterdam UMC announced the launch of two clinical trials; the first which has started meanwhile will assess the performance of a new PET ligand that can measure synaptic density in the living brain; the outcome of this first trial should provide insights to guide Rodin’s upcoming Phase 1b trial […]
News
Scale up Photanol BV to build demonstration plant at AkzoNobel site in Delfzijl
Photanol BV has closed a substantial new financing round to demonstrate its industrial capabilities to produce chemicals from CO2 and sunlight. Photanol BV is a spin-off company established in 2008 by UvA Ventures Holding in collaboration with the Swammerdam Institute for Life Sciences of the UvA’s Faculty of Science. Photanol uses modified cyanobacteria to produce […]
News
Entrepreneurship for Artificial Intelligence and Computer Science
New elective : Entrepreneurship for Artificial Intelligence and Computer Science In recent years, academic entrepreneurship education has shifted from the exclusive domains of business administration and economics to many other domains as well. In April/May 2019, entrepreneurship is taught for the first time to students of the master Computer Science (joint degree of the Vrije […]
News